Pricing Pressures Lower Profits For Chinese Drug Chain Nepstar, While Healthcare Reform Has Opposite Effect On Hospital Chain Chindex - China Earnings Roundup (Part 1)

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.